Advertisement Pharmaceutical Business review - Page 836 of 5273 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 19, 2026

Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates

Regeneron Pharmaceuticals has signed a $2.32bn research collaboration with Parabilis Medicines to develop therapeutic candidates leveraging the latter’s Helicon peptide platform, with an emphasis on antibody-Helicon conjugates (AHCs).

Continue
The partnership will investigate Helicons as standalone therapies and as components of AHCs for potential new therapies. Credit: Gorodenkoff / Shutterstock.com.
May 19, 2026

VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain

VERTANICAL is undertaking a pivotal Phase III US trial for future FDA submission. Credit: Gorodenkoff / Shutterstock.com.
May 18, 2026

Japan’s MHLW approves Boehringer’s Jascayd for IPF and PPF

Nerandomilast met the primary endpoint in the FIBRONEER-IPF study. Credit: Tapati Rinchumrus / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. FDA approves Enhertu for two HER2-positive early breast cancer indications
  2. Arna Pharma and Slate Run complete JV for new US company
  3. Kyowa Kirin secures FDA approval for Crysvita dosing update
  4. Zydus to acquire Assertio in $166m deal
  5. Pfizer receives EC approval for Hympavzi to treat haemophilia

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography